These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9635002)

  • 1. Cyclosporine distribution into the conjunctiva, cornea, lacrimal gland, and systemic blood following topical dosing of cyclosporine to rabbit, dog, and human eyes.
    Acheampong A; Shackleton M; Lam S; Rudewicz P; Tang-Liu D
    Adv Exp Med Biol; 1998; 438():1001-4. PubMed ID: 9635002
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs.
    Acheampong AA; Shackleton M; Tang-Liu DD; Ding S; Stern ME; Decker R
    Curr Eye Res; 1999 Feb; 18(2):91-103. PubMed ID: 10223652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
    Moore CP; McHugh JB; Thorne JG; Phillips TE
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):653-9. PubMed ID: 11222523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy.
    Gao J; Schwalb TA; Addeo JV; Ghosn CR; Stern ME
    Cornea; 1998 Nov; 17(6):654-63. PubMed ID: 9820947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of cyclosporine A in ocular tissues after topical administration of cyclosporine A cationic emulsions to pigmented rabbits.
    Daull P; Lallemand F; Philips B; Lambert G; Buggage R; Garrigue JS
    Cornea; 2013 Mar; 32(3):345-54. PubMed ID: 23023401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a rabbit model for keratoconjunctivitis sicca.
    Chen ZY; Liang QF; Yu GY
    Cornea; 2011 Sep; 30(9):1024-9. PubMed ID: 21659853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tear protein profiles vs. clinical characteristics of untreated and cyclosporine-treated canine KCS.
    Fullard RJ; Kaswan RM; Bounous DI; Hirsh SG
    J Am Optom Assoc; 1995 Jul; 66(7):397-404. PubMed ID: 7560726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjunctival impression cytology from dogs with keratoconjunctivitis sicca. Pre- and post-treatment with topical cyclosporine.
    Bounous DI; Krenzer KL; Kaswan RL; Hirsh SG
    Adv Exp Med Biol; 1998; 438():997-1000. PubMed ID: 9635001
    [No Abstract]   [Full Text] [Related]  

  • 9. Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White Rabbits.
    Weiss SL; Kramer WG
    J Ocul Pharmacol Ther; 2019 Sep; 35(7):395-402. PubMed ID: 31355703
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs.
    Morgan RV; Abrams KL
    J Am Vet Med Assoc; 1991 Oct; 199(8):1043-6. PubMed ID: 1748607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dose-ranging clinical trial to assess the safety and efficacy of cyclosporine ophthalmic emulsion in patients with keratoconjunctivitis sicca. The Cyclosporine Study Group.
    Tauber J
    Adv Exp Med Biol; 1998; 438():969-72. PubMed ID: 9634996
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
    Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS
    Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of corneal and conjunctival metaplasia by impression cytology during the treatment of canine keratoconjunctivitis sicca.
    Radziejewski K; Balicki I; Szadkowski M
    Acta Vet Hung; 2018 Jun; 66(2):189-203. PubMed ID: 29958527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiles of aquaporins in rat conjunctiva, cornea, lacrimal gland and Meibomian gland.
    Yu D; Thelin WR; Randell SH; Boucher RC
    Exp Eye Res; 2012 Oct; 103():22-32. PubMed ID: 22828047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs.
    Olivero DK; Davidson MG; English RV; Nasisse MP; Jamieson VE; Gerig TM
    J Am Vet Med Assoc; 1991 Oct; 199(8):1039-42. PubMed ID: 1748606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of topical nerve growth factor treatment in dogs affected by dry eye.
    Coassin M; Lambiase A; Costa N; De Gregorio A; Sgrulletta R; Sacchetti M; Aloe L; Bonini S
    Graefes Arch Clin Exp Ophthalmol; 2005 Feb; 243(2):151-5. PubMed ID: 15650854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.
    Barachetti L; Rampazzo A; Mortellaro CM; Scevola S; Gilger BC
    Vet Ophthalmol; 2015 May; 18(3):234-41. PubMed ID: 24799029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.
    Parrilha LR; Nai GA; Giuffrida R; Barbero RC; Padovani LD; Pereira RH; Silva DA; Silva MC; Diniz MS; Andrade SF
    Arq Bras Oftalmol; 2015; 78(5):295-9. PubMed ID: 26466228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of keratoconjunctivitis sicca in dogs with cyclosporine ophthalmic ointment: a European clinical field trial.
    Sansom J; Barnett KC; Neumann W; Schulte-Neumann A; Clerc B; Jegou JP; de Haas V; Weingarten A
    Vet Rec; 1995 Nov; 137(20):504-7. PubMed ID: 8588275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of keratoconjunctivitis sicca in rabbits with 3-isobutyl-1-methylxanthine.
    Gilbard JP
    Arch Ophthalmol; 1994 Dec; 112(12):1614-6. PubMed ID: 7527631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.